{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:20:09Z","timestamp":1789672809812,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000},"content-version":"vor","delay-in-days":957,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.pedneo.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T17:00:17Z","timestamp":1367168417000},"page":"219-227","source":"Crossref","is-referenced-by-count":146,"title":["Pompe Disease: Early Diagnosis and Early Treatment Make a Difference"],"prefix":"10.1016","volume":"54","author":[{"given":"Yin-Hsiu","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2013.03.009_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.pedneo.2013.03.009_bib2","first-page":"304","article-title":"Over idiopatische hypertrophie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned Tijdshr Geneeskd"},{"key":"10.1016\/j.pedneo.2013.03.009_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/scientificamerican0563-64","article-title":"The lysosome","volume":"208","author":"De Duve","year":"1963","journal-title":"Sci Am"},{"key":"10.1016\/j.pedneo.2013.03.009_bib4","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.03.009_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2013.03.009_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2013.03.009_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pedneo.2013.03.009_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2013.03.009_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2011.06.010","article-title":"Rapid progressive course of later-onset Pompe disease in Chinese patients","volume":"104","author":"Yang","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01799482","article-title":"Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity","volume":"10","author":"Lin","year":"1987","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pedneo.2013.03.009_bib12","first-page":"224","article-title":"Glycogen storage disease type II in Israel","volume":"24","author":"Bashan","year":"1988","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.pedneo.2013.03.009_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000016192","article-title":"Glycogen storage disease type II: birth prevalence agrees with predicted genotype frequency","volume":"2","author":"Ausems","year":"1999","journal-title":"Community Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib15","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.03.009_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2013.03.009_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for Pompe disease newborn screening: results from the taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pedneo.2013.03.009_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/humu.22108","article-title":"Update of the Pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants","volume":"33","author":"Kroos","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pedneo.2013.03.009_bib21","first-page":"887","article-title":"Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II","volume":"56","author":"Boerkoel","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/(SICI)1098-1004(1999)13:5<380::AID-HUMU6>3.0.CO;2-A","article-title":"Molecular genetic study of Pompe disease in Chinese patients in Taiwan","volume":"13","author":"Ko","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pedneo.2013.03.009_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype-phenotype correlation in Pompe disease","volume":"160","author":"Kroos","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<306::AID-HUMU8>3.0.CO;2-S","article-title":"Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: evidence for a founder effect","volume":"11","author":"Shieh","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pedneo.2013.03.009_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2011.01.006","article-title":"Improved assay for differential diagnosis between Pompe disease and acid alpha-glucosidase pseudodeficiency on dried blood spots","volume":"103","author":"Shigeto","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","article-title":"Structural and biochemical studies on Pompe disease and a \u201cpseudodeficiency of acid alpha-glucosidase\u201d","volume":"52","author":"Tajima","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1469-1809.1996.tb00433.x","article-title":"Identification of an E689K substitution as the molecular basis of the human acid alpha-glucosidase type 4 allozyme (GAA*4)","volume":"60","author":"Huie","year":"1996","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jmb.2005.08.020","article-title":"Loss of protein structure stability as a major causative factor in monogenic disease","volume":"353","author":"Yue","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pedneo.2013.03.009_bib30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jmb.2005.12.025","article-title":"Identification and analysis of deleterious human SNPs","volume":"356","author":"Yue","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pedneo.2013.03.009_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj2890681","article-title":"Human lysosomal alpha-glucosidase: functional characterization of the glycosylation sites","volume":"289","author":"Hermans","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.pedneo.2013.03.009_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0009-8981(78)90328-5","article-title":"Alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state","volume":"89","author":"Taniguchi","year":"1978","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pedneo.2013.03.009_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0009-8981(85)90295-5","article-title":"Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells","volume":"148","author":"Shin","year":"1985","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pedneo.2013.03.009_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cccn.2005.05.025","article-title":"Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease","volume":"361","author":"Umapathysivam","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pedneo.2013.03.009_bib36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/clinchem\/46.9.1318","article-title":"Determination of acid alpha-glucosidase protein: evaluation as a screening marker for Pompe disease and other lysosomal storage disorders","volume":"46","author":"Umapathysivam","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.pedneo.2013.03.009_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pedneo.2013.03.009_bib38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.pedneo.2013.03.009_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2005.10.016","article-title":"A new diagnostic assay for glycogen storage disease type II in mixed leukocytes","volume":"88","author":"Okumiya","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0167-4781(96)00093-0","article-title":"Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice","volume":"1308","author":"Bijvoet","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pedneo.2013.03.009_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.93.1.65","article-title":"High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease","volume":"93","author":"Van Hove","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pedneo.2013.03.009_bib42","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2013.03.009_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"Nicolino","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.pedneo.2013.03.009_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pedneo.2013.03.009_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.pedneo.2013.03.009_bib46","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1542\/peds.2003-0988-L","article-title":"Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease","volume":"114","author":"Hunley","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.03.009_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/GIM.0b013e3182174703","article-title":"The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease","volume":"13","author":"Banugaria","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.pedneo.2013.03.009_bib48","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.cca.2012.04.012","article-title":"Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: application to a small-scale population study for five lysosomal storage disorders","volume":"413","author":"Orsini","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pedneo.2013.03.009_bib49","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1373\/clinchem.2005.064915","article-title":"Immunochemistry of lysosomal storage disorders","volume":"52","author":"Parkinson-Lawrence","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.pedneo.2013.03.009_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.semperi.2009.12.008","article-title":"Digital microfluidics: a future technology in the newborn screening laboratory?","volume":"34","author":"Millington","year":"2010","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.pedneo.2013.03.009_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pedneo.2013.03.009_bib52","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2013.03.009_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2009.03.015","article-title":"Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease","volume":"155","author":"Chen","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2013.03.009_bib54","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cardfail.2011.07.011","article-title":"Left ventricular geometry, global function, and dyssynchrony in infants and children with pompe cardiomyopathy undergoing enzyme replacement therapy","volume":"17","author":"Chen","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.pedneo.2013.03.009_bib55","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2013.03.009_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.c.31321","article-title":"Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations","volume":"160","author":"Case","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib57","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pedneo.2013.03.009_bib58","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","article-title":"Nervous system in Pompe's disease. Ultrastructure and biochemistry","volume":"30","author":"Gambetti","year":"1971","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pedneo.2013.03.009_bib59","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.pedneo.2013.03.009_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib61","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1212\/WNL.0b013e3182553c11","article-title":"Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy","volume":"78","author":"Ebbink","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2013.03.009_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","article-title":"Oropharyngeal dysphagia in infants and children with infantile Pompe disease","volume":"25","author":"Jones","year":"2010","journal-title":"Dysphagia"},{"key":"10.1016\/j.pedneo.2013.03.009_bib63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","article-title":"Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy","volume":"35","author":"van Gelder","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pedneo.2013.03.009_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1203\/01.pdr.0000233014.84318.4e","article-title":"Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy","volume":"60","author":"Chien","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pedneo.2013.03.009_bib65","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ymgme.2010.08.001","article-title":"Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy","volume":"101","author":"Raben","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib66","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.pedneo.2013.03.009_bib67","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ymgme.2012.01.019","article-title":"Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells","volume":"105","author":"Banugaria","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2013.03.009_bib68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/gim.2011.4","article-title":"Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease","volume":"14","author":"Messinger","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.pedneo.2013.03.009_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160","author":"Bali","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.pedneo.2013.03.009_bib70","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj2890687","article-title":"The conservative substitution Asp-645\u2013>Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II","volume":"289","author":"Hermans","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.pedneo.2013.03.009_bib71","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/mt.2009.37","article-title":"Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease","volume":"17","author":"Zhu","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.pedneo.2013.03.009_bib72","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","article-title":"Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice","volume":"101","author":"LeBowitz","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pedneo.2013.03.009_bib73","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1074\/jbc.M112.438663","article-title":"Glycosylation-independent lysosomal targeting of acid alpha-glucosidase enhances muscle glycogen clearance in pompe mice","volume":"288","author":"Maga","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pedneo.2013.03.009_bib74","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pedneo.2013.03.009_bib75","doi-asserted-by":"crossref","first-page":"e40776","DOI":"10.1371\/journal.pone.0040776","article-title":"The pharmacological chaperone AT2220 increases recombinant human acid alpha-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease","volume":"7","author":"Khanna","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pedneo.2013.03.009_bib76","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/mt.2012.152","article-title":"Pharmacological enhancement of alpha-glucosidase by the allosteric chaperone N-acetylcysteine","volume":"20","author":"Porto","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.pedneo.2013.03.009_bib77","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","article-title":"Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase","volume":"96","author":"Amalfitano","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pedneo.2013.03.009_bib78","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/mt.2008.133","article-title":"Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy","volume":"16","author":"Sun","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.pedneo.2013.03.009_bib79","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1182\/blood-2009-11-252874","article-title":"Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype","volume":"115","author":"van Til","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2013.03.009_bib80","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol Ther"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957213000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957213000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T18:16:01Z","timestamp":1644862561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957213000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1875957213000454"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2013.03.009","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}